about
The immune pathogenesis of scleroderma: context is everythingCurrent perspectives on the immunopathogenesis of systemic sclerosisRedox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseAnimal models of systemic sclerosis: their utility and limitations.Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation.The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort.Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange.Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.Making progress: preserving beta cells in type 1 diabetes.Novel investigational agents for the treatment of scleroderma.Hematopoietic stem cell transplantation in children with autoimmune connective tissue diseases.Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.Diffuse systemic sclerosis with bullous lesions without systemic manifestations.Role of the mTOR pathway in minor salivary gland changes in Sjogren's syndrome and systemic sclerosis
P2860
Q24633658-42F380AB-D269-4EDA-BC59-5B063FF8BBF4Q26741264-67DB013E-C015-4CA2-838A-4EBAACC26471Q26824042-7B05444D-719D-4302-8CC9-79565517B768Q28390528-B46D6B03-BE43-42A7-BE99-8AA881ED84F8Q36103216-34BA3F24-5B06-4038-BFCA-D1E97A67B83EQ36151396-00C29F86-5C06-4CA7-951B-8ED865E8FA38Q37198362-A35CB5AE-B8F9-4AA3-891F-FD17085C57A2Q37690732-0C7F88E8-14B0-4D0B-87CB-2C539E97F341Q37972677-09953AEB-D6F0-4D6B-B1C9-CDFA4D3723D1Q38164818-3C94985D-BBB5-48E3-AF33-75A61DD42618Q38194074-720CD680-D43D-4603-B600-DBD3AE31B439Q38379767-C1ACCC46-78D0-4F2D-8C95-5E91043B2CCCQ39233347-138E6C3F-740C-4B1F-B7B5-03A3EF7AD354Q41223874-DACEF3E4-6ED5-4C89-99A8-D24E6DC7E381Q41854087-67614F45-994B-4C91-AF82-4C92C7562BB1Q58800566-BB6B1632-25AD-4134-8053-699AC7E1F191
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunotherapy of systemic sclerosis
@ast
Immunotherapy of systemic sclerosis
@en
Immunotherapy of systemic sclerosis
@nl
type
label
Immunotherapy of systemic sclerosis
@ast
Immunotherapy of systemic sclerosis
@en
Immunotherapy of systemic sclerosis
@nl
prefLabel
Immunotherapy of systemic sclerosis
@ast
Immunotherapy of systemic sclerosis
@en
Immunotherapy of systemic sclerosis
@nl
P2860
P3181
P356
P1433
P1476
Immunotherapy of systemic sclerosis
@en
P2093
Francesco Boin
Rebecca Manno
P2860
P304
P3181
P356
10.2217/IMT.10.69
P407
P577
2010-11-01T00:00:00Z